Thus, it is speculated that HPS2 patients develop pulmonary fibrosis and tumorigenesis mainly due to immunodeficiency, implying that AP-3 plays a key role in regulating the immune response and maintaining immune homeostasis. Here, AP3B1 is linked to pulmonary fibrosis.